Skip to content

Frontlight ResearchEarly access

Trial site

Instituto do Cancer do Ceara (Site 2703)

Fortaleza, Ceará 60430-230, BrazilNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Endometrial cancer

Closed trials

Completed
Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001)
NCT03884101· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Instituto do Cancer do Ceara (Site 2703): trial site – Frontlight Research